Credit Suisse’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$298M Sell
747,649
-138,689
-16% -$52.4M 0.29% 61
2023
Q4
$299M Sell
886,338
-30,122
-3% -$8.98M 0.29% 64
2023
Q3
$268M Buy
916,460
+29,686
+3% +$9.27M 0.27% 65
2023
Q2
$303M Sell
886,774
-186,311
-17% -$56.4M 0.3% 56
2023
Q1
$274M Sell
1,073,085
-36,955
-3% -$9.1M 0.28% 62
2022
Q4
$295M Sell
1,110,040
-70,114
-6% -$17.1M 0.31% 60
2022
Q3
$221M Sell
1,180,154
-27,647
-2% -$5.94M 0.25% 71
2022
Q2
$242M Buy
1,207,801
+39,596
+3% +$9.29M 0.25% 67
2022
Q1
$352M Sell
1,168,205
-20,455
-2% -$5.98M 0.3% 59
2021
Q4
$427M Sell
1,188,660
-266,550
-18% -$91.7M 0.23% 67
2021
Q3
$482M Buy
1,455,210
+14,130
+1% +$4.74M 0.27% 54
2021
Q2
$442M Sell
1,441,080
-28,362
-2% -$7.96M 0.23% 64
2021
Q1
$362M Buy
1,469,442
+194,373
+15% +$48.9M 0.19% 94
2020
Q4
$348M Buy
1,275,069
+83,673
+7% +$20.8M 0.17% 109
2020
Q3
$282M Sell
1,191,396
-397,752
-25% -$89.3M 0.17% 105
2020
Q2
$302M Buy
1,589,148
+302,232
+23% +$54.2M 0.22% 89
2020
Q1
$212M Sell
1,286,916
-28,467
-2% -$5.21M 0.18% 110
2019
Q4
$259M Buy
1,315,383
+44,535
+4% +$8.34M 0.19% 91
2019
Q3
$229M Sell
1,270,848
-109,920
-8% -$19M 0.19% 86
2019
Q2
$241M Buy
1,380,768
+189,078
+16% +$32.4M 0.21% 81
2019
Q1
$227M Buy
1,191,690
+45,522
+4% +$8.09M 0.21% 78
2018
Q4
$183M Buy
1,146,168
+83,277
+8% +$14.1M 0.19% 88
2018
Q3
$203M Sell
1,062,891
-202,200
-16% -$35.9M 0.18% 86
2018
Q2
$202M Sell
1,265,091
-187,509
-13% -$28.6M 0.2% 85
2018
Q1
$200M Buy
1,452,600
+180,153
+14% +$25.1M 0.19% 91
2017
Q4
$155M Buy
1,272,447
+162,054
+15% +$20.3M 0.14% 132
2017
Q3
$129M Buy
1,110,393
+47,619
+4% +$5.19M 0.13% 155
2017
Q2
$110M Buy
1,062,774
+61,560
+6% +$5.92M 0.11% 175
2017
Q1
$85.3M Buy
1,001,214
+107,685
+12% +$8.51M 0.08% 253
2016
Q4
$63M Buy
893,529
+23,913
+3% +$1.76M 0.06% 322
2016
Q3
$70M Buy
869,616
+113,040
+15% +$8.66M 0.07% 301
2016
Q2
$55.6M Buy
756,576
+49,923
+7% +$3.51M 0.06% 330
2016
Q1
$47.2M Sell
706,653
-250,965
-26% -$15.6M 0.06% 364
2015
Q4
$58.1M Buy
957,618
+69,714
+8% +$3.92M 0.07% 320
2015
Q3
$45.3M Sell
887,904
-56,133
-6% -$3.18M 0.05% 388
2015
Q2
$50.8M Buy
944,037
+2,871
+0.3% +$161K 0.05% 410
2015
Q1
$52.8M Sell
941,166
-155,763
-14% -$8.82M 0.05% 402
2014
Q4
$64.5M Sell
1,096,929
-98,091
-8% -$5.46M 0.06% 357
2014
Q3
$61.3M Buy
1,195,020
+208,035
+21% +$10.3M 0.05% 409
2014
Q2
$45.2M Sell
986,985
-8,019
-0.8% -$354K 0.04% 527
2014
Q1
$48.4M Sell
995,004
-236,619
-19% -$11.1M 0.05% 429
2013
Q4
$52.6M Buy
1,231,623
+182,142
+17% +$7.66M 0.05% 394
2013
Q3
$43.9M Sell
1,049,481
-88,101
-8% -$3.89M 0.04% 398
2013
Q2
$64M Buy
+1,137,582
New +$62.7M 0.06% 296

Other funds holding ISRG

Credit Suisse's ISRG Position: Q1 2024 in Review

Credit Suisse reduced its Intuitive Surgical (ISRG) stake by 16% in Q1 2024, selling an estimated $52.4M and leaving 747,649 shares worth $298M. The position accounts for 0.29% of the portfolio, ranked #61.

Credit Suisse first reported a position in ISRG in Q2 2013 and has held it in 44 quarters since. The position peaked at $482M in Q3 2021. 1,742 funds tracked by Wall St. Rank hold ISRG as of Q1 2024.

  • Credit Suisse held 747,649 shares of Intuitive Surgical worth $298M as of Q1 2024.
  • Credit Suisse sold 138,689 Intuitive Surgical shares in Q1 2024, an estimated $52.4M.
  • Intuitive Surgical made up 0.29% of Credit Suisse's portfolio in Q1 2024, its #61 holding.
  • Credit Suisse first reported a position in Intuitive Surgical in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Intuitive Surgical position peaked at $482M in Q3 2021.
  • 1,742 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.